|Articles|February 3, 2009

Astaxanthin May Lower Blood Pressure

Astaxanthin has the ability to significantly lower systolic blood pressure in rats, according to a new study performed at Georgetown University Medical Center.

Astaxanthin has the ability to significantly lower systolic blood pressure in rats, according to a new study performed at Georgetown University Medical Center. This study joins three other past studies performed at the Toyama Medical and Pharmaceutical University in Japan which researched astaxanthin’s ability to reduce hypertension as well mechanism of actions for this benefit.

In the Georgetown University study, tests suggested that the Renin-Angiotensin system was involved in the ability of astaxanthin to lower blood pressure. Also, at higher dosage levels it was shown that astaxanthin influenced circulating TNF-α and MCP-1 and lessened fat oxidation in the liver and kidneys. This is an indication that astaxanthin may help to reduce stress.

The study was sponsored by Fuji Chemical Industry (Japan) and performed using AstaREAL astaxanthin.


Related to this article

SupplySide Global Vitaquest
Live from SupplySide Global 2026, Nutritional Outlook’s Nicholas Jacobus speaks with Michael Anthonavage, VP of innovation at Vitaquest International, about the company’s 2027 consumer trends forecast and how it’s shaping supplement formulation.
Laurentia Bliss
Live from SupplySide Global 2026, Laurentia Bliss talks about new athlete-focused research on Magtein, ThreoTech’s brain-targeted magnesium ingredient, and upcoming innovations like effervescent tablets and gummies.
Klaus Neumann
Live from SupplySide Global 2026, Klaus Neumann talks about Concordix's chewable supplement line spanning beauty and gut-immune health, including BeautyBioti, a Skin & Hair Vitality Complex, and FortiBiotic.